chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2 weeks after first vaccine developed myalgias and arthralgias. These symptoms progressed and worsened over time and especially after the second vaccine. She developed swelling in hands and feet and moderate to severe pain in muscles and joints requiring pain medications. The swelling and pain responded to prednisone but soon recurred after completing the prednisone.
Rapid onset of all symptoms of H1N1 flu.  Went to bed; fever reduced at about 11:00 PM.  Stomach pain mostly gone by 6:00 AM, but unable to eat complete meal until 12/06/2009.  Most symptoms alleviated by 12/07/2009.  Still experiencing fatigue 12/08/2009.
I have a broken shoulder and my humerus bone broke; I have a broken shoulder and my humerus bone broke; May be just felt a little bit of a sore arm; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 49-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and expiration date was not reported) via an unknown route of administration on 05May2021 as 2 nd dose, single for Covid-19 immunization. The patient received co suspect Ibuprofen (IBUPROFEN) 800 mg in the morning (Batch/Lot number: not reported), Paracetamol (TYLENOL) 1000 mg (around 12 took Tylenol 1000 mg) (Batch/Lot number was not reported) via an unknown route of administration on an unknown date for an unknown indication. The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 on an unknown date as SINGLE for Covid-19 immunization and experienced no adverse event.  On an unknown date, the patient experienced to have a broken shoulder and humerus bone broke and may be just felt a little bit of a sore arm. It was reported that patient had been hearing multiple news conferences about aspirin and ibuprofen when receive Pfizer vaccinations as it lowers the dose of vaccination. It was reported that patient was informed not to take Ibuprofen and Tylenol whatsoever and patient had been taking it all long like Ibuprofen 800 mg in the morning and then Tylenol 1000 mg around 12  and patient did not felt the first vaccine even the second vaccine patient did not feel nothing. May be just felt a little bit of a sore arm other than that nothing and patient do not feel protected. The outcome of the events was unknown.    No follow-up attempts were possible; information about lot/batch number cannot be obtained.
He developed a high fever of 104F, acute onset body chills, fatigue while he was in the bath on a Friday evening. He said he felt very cold in a warm bath and had some congestion. I decided to check his temperature; when we noticed how high his fever was, we gave him ibuprofen. The next morning, his fever was still pretty high so we decided to take him to the urgent care shortly after on 01/07/2023. They tested him for strep and viral infection panel including COVID-19, pneumonia, RSV and others. no change in treatment; they prescribed him MOTRIN and told us to keep him hydrated and allow him to rest. Three weeks prior, he had been treated with a steroid and antibiotic for congestion and early signs of pneumonia. They prescribed him prednisone at that time. He slowly got better, but my wife and I thought it was a second infection that could be developing which triggered this current one. Right now, he's doing much better and feeling fine.
This case was reported by a pharmacist via sales rep and described the occurrence of lip swelling in a adult patient who received FLUARIX quadrivalent. In 2015, the patient received FLUARIX quadrivalent 1 ml. On an unknown date, an unknown time after receiving FLUARIX quadrivalent, the patient experienced lip swelling. on an unknown date, the outcome of the lip swelling was unknown. It was unknown if the reporter considered the lip swelling to be related to FLUARIX quadrivalent. Additional detials provided were as follows: The sales rep reportedthat, a pharmacist provided vacicnations to their hospital employees. An unspecified time after receiving the vaccine, the patient experienced swollen upper lip (lip swelling). The reproter did not have batch number, expiration date or any other information. This was 1 of the 3 cases reported by the same reporter (see cases US2015152961 and US2015152966).
swelling lip, throat swollen, rash all over body; did not contact MD gave DPH po only;
Woke at 2am to nausea, then vomiting, then severe body aches, chills, sweats, light fever, headache
calling for temperature evaluation for VARIVAX and notifed it was administered to multiple patients; This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. On 15-JUN-2020, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX)(strength, dosing schedule, lot#, expiration date and route of administration were not provided) for prophylaxis. Administered dose of vaccine was exposed to the temperature from -14 Celsius degrees to -10 Celsius degrees for 4 hours 15 minutes. There was a previous temperature excursion noted: from -9 Celsius degrees to 8 Celsius degrees for 2 hours 21 minutes, as recorded by a digital data logger.  This is one of multiple reports from the same reporter.; Sender's Comments:  US-009507513-2007USA003458: US-009507513-2007USA004416:
The pt arrived at the ER complaining of vomiting, screaming, swelling of eyes and was respiratory compromised which started approximately 40 minutes after receiving vax.
He stated that he recently had an injection of Pneumovax and he now has left arm pains. The injection was in the left deltoid muscle. The soreness at the site of the injection is resolving but he now admits to pain and tenderness of the left upper arm. No report of fevers, chill, pruritis or shortness of breath.
pain started w/in 8min of shot;severe pain in head, especially on lt side of face that involved ear, eye, & along jaw line;pain in this area has cont over past yr;exp muscle spasms in neck & sometimes in legs or feet;
Breakthrough case admission after 3 vaccines Moderna 8/12/21 Lot# 033C21A;  Moderna 9/17/21 Lot# 025B21A;  Moderna 3/2/22 Lot# 022J21A
Pt vaccinated with MMR developed swelling of rt parotid gland w/pain.
Immedietly after shot, was very sleepy and lethargic.  About 24 hours after shot, vomiting, chills, hot flashes, and diarrhea occured, lasting approx 11 hours.  For next 24 hours, chills, hot flashes, and some diarrhea.   No treatment administered.
On 10/5 around 5:30pm went to a historical marker at the cemetary. Patient had an acute episode of flash in eyes, headache and then numbness in both arms and legs and feet and also heaviness of chest that felt like patient was pulling down to the ground. Made it back to car, sat there for a while and returned back baseline. The next day had 3 episodes. The following day, lasting 10-15 minutes each. Patient had episodes 10/5-9 daily, occasionally it is numbness and tingling, face, mouth, hands, feet and feet.  On 10/10 woke up feeling fine had a more severe reaction, thought was having a stroke, called 911 but was still very aware and precise. Patient was evaluated by CT scan and everything was negative. Numbness involves the entire body, and is not unilateral.  Was seen by Family doctor and was given Valtrex x 10d - finished on 10/23. Was seen by neurology and was told has cervical spine problems. Had an MRI and has a lot of cervical disease.  Was seen by Dr. yesterday and there is extensive disease. Patient did a lot of heavy lifting.  Does have cervical disease but it does not explain the numbness in face and mouth.  These days it has not been occurring on face and mouth anymore.  The pt still is having episodes 2-3 x a day.
A couple of hours after receiving HPV vaccine, patient developed hives and was itching all over her body.  Denied any new products being used or eating any new foods or taking any other medication.
On 3SEP91 pt had t105.0 fever & was fine the next day;
Received 1st Moderna dose 02/23/2021. Noticed small scaly bumps in the small of my back about 3 days after shot. The bumps continued to mulitply and then on 3/11/2021, I removed my clothes for nightly shower to discover that my trunk on both sides were covered in small, dark bumps/welts.  No itching, no oozing, no pain. They were sensitive to touch but not unbearable. Freaked out because what had started in the small of my back had now spread to my trunk. Went immediately to emergency room where ER doctor diagnosed as shingles, but I told him this made no sense as I had been twice vaccinated against chickenpox (elementary school and upon entry into USAF; but also that I had never had chickenpox nor been exposed to anyone who had it or shingles. He then diagnoses as folliculitis - but again I told him this made no sense, because it had spread from my back to my front. I told him that the only new "thing" that had been introduced into my system was the 1st dose of Moderna to which he finally admitted he had no clue about any side effects from from any of the vaccines.  I took my 2nd dose yesterday 3/23/2021 and am 32 hours in. Besides the aches and slight fever, I have noticed that the bumps/welts have returned and are turning red. They had begun to resolove and were turning dark brown and going away.  I was prescribed Vibramycin and Predinisone and also counseled to get a skin biopsy, but I have not heard back from the hospital. My healthcare comes through the VA here.   I have photos from the first incident and have just taken new photos an hour ago for comparison and contrast and would be happy to share these with the CDC. *Please note: I do not have the lot/batch number for 2nd dose. The Health Department did not/does not provide this information at the time of vaccinations. We have to call back down to get this.
SORE THROAT; MORE RUNNY DIARRHEA; This spontaneous report received from a patient concerned a 66 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 21-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced sore throat. On 08-APR-2021, the subject experienced more runny diarrhea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore throat on 08-APR-2021, and the outcome of more runny diarrhea was not reported. This report was non-serious.
Shot was on Wed. Started with extremely high blood sugar that last around 4 days.  Then Sunday developed severe admonish pain.  Pain lasted into Monday.  Then Monday around 10am developed a severe allergic reaction started both hands started to itch really bad, then it spread to middle section, legs, neck, under arms started to get hives which I never experienced before.  Then my hands, lips, neck and esophagus started to swell up.  My esophagus felt made me nausea and I tried to throw up but nothing came out.  I went to ER and just about collapsed before I could be seen.  While waiting the benadryl I took started to work so by the time I saw doctor hives started to subside and itching not has bad.
The mother states," he cried a lot that night, three days later and took him to the doctor." Red and purple, and warm to touch at injection site. Mother gave the pt Motrin and applied ice. The doctor provided no treatment.
after takeing the shots one day latter i got sick for only one day but after that day i have never got the covd19 again it works
Pt received Tdap and MENVEO on 8/21/2012 on the right deltoid in our facility. Patient RTC on 8/23/2012 and complained redness and swelling on right deltoid. The swelling is 100 mm x 80 mm on right. Pt denies SOB. Pt was evaluated by Dr. and discharge home with no acute distress.
Acute inflammatory eye disease, vasculitis, iritis The first signs showed up the morning of 02/07/2021.  I went to the eye doctor on 02/08/2021.  Symptoms kept getting worse and I was referred to a retina specialist on 02/10/2021.  I go back on Wednesday 02/17/2021.  The retina doctor and family doctor have talked and they are recommending that I do not get the second dose at this time because I could be at risk of vision loss.
This case was reported by a consumer via call center representative and described the occurrence of injection site irritation in a male patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. In April 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX and not applicable after receiving SHINGRIX, the patient experienced injection site irritation, injection site pain, injection site discomfort and product supply issue. On an unknown date, the outcome of the injection site irritation, injection site pain and injection site discomfort were recovered/resolved and the outcome of the product supply issue was unknown.  It was unknown if the reporter considered the injection site irritation, injection site pain and injection site discomfort to be related to SHINGRIX. Additional information was received as follows: The age at vaccination was not reported. The patient stated that, he experienced injection site reaction which included irritation, pain and discomfort which resolved. The patient called due to being upset with the backorder situation with the product and so not all the questions for adverse event report were obtained.
Information has been received from a reporter concerning a patient who was vaccinated with PNEUMOVAX 23 (manufacturer unknown). On an unspecified date the patient experienced severe cellulitis and "was in hospital" (date and duration unspecified). The outcome of the patient was not reported. This report was received from Watson Pharmaceuticals. Follow-up information received from a licensed practical nurse (L.P.N.) concerning a 58 year old patient who on 01-MAR-2010 was vaccinated with a dose of PNEUMOVAX 23 (lot number 665400/1315Y). In March 2010, the patient was diagnosed with cellulitis and was hospitalized. The patient's hospitalization dates were unknown to the L.P.N. It was unknown to the L.P.N. if the patient's cellulitis was disabling or life-threatening. On 16-MAR-2010 the patient had a follow-up visit and the patient had recovered. It was also stated that other patient had received the vaccine from the same vial as this patient and the patients have not had any adverse reactions. This is one of several reports from the same source. Additional information has been requested.
Hospitalization for COPD exacerbation, COVID 1/18/22-1/20/22. Treated with baricitinib, remdesivir, dexamethasone, zinc 50 mg daily, vitamin D3 50 mcg daily and vitamin C 1,000 mg daily
breast tenderness outside of her breast; soreness and swelling under her arms; swelling under her arms; This is a spontaneous report from a contactable consumer (patient) via medical information team. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date, the patient received Pfizer COVID vaccine and stated she had breast tenderness outside of her breast that lasted a few days and soreness and swelling under her arms. She reported that the breast tenderness was closest to the armpit. The outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Terrible migraine on front left head; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 at 18:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included systemic lupus erythematosus (SLE) and rheumatoid arthritis. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 25Mar2021 (at the age of 48-year-old) as a single dose for COVID-19 immunisation.  On 23Apr2021 at 07:00, the patient experienced terrible migraine on front left head. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event terrible migraine on front left head was resolving at the time of this report.    No follow up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Patient with CLL admitted through the ED with hypoxemia and fever.  She presented with decreased appetite, fatigue, and dyspnea on exertion.  On 1/11/22 the patient acutely worsened, likely from sepsis due to Covid-19.  She was transferred to ICU for increased oxygenation needs requiring high flow nasal cannula.  Remdesivir and dexamethsone completed.  Comfort care was initiated on 1/17/22 and the patient expired on 1/19/22.
Fever, limb aches on side of injection, headache, lethargy.  Symptoms primarily lasted for 18 hours.  May be still be feeling tired, not certain if related to shot.
Hives beginning on 28 December 2021 and still occurring as of 4 January 2022.  Slight reduction with prednisone 5 days, after the five days symptoms worsened. Also taking hydroxyzine, famotidine.
This spontaneous case was initially received on 09-Oct-2015. The case report was received from a Health Professional and concerns a patient with unknown age and gender. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. Suspect drug (s), timing and conditions surrounding the onset of reaction (s)/event (s): The patient received AFLURIA for indication protection against seasonal influenza virus on 08-Oct-2015- 08-Oct-2015, Batch no: T57505, Route of administration: Intramuscular, Dose: 0.5 ml. Additional suspect drug (s); No additional drugs suspected. Reaction (s)/event (s) and outcome: On 08-Oct-2015, the patient experienced received an IM (intramuscular) dose of AFLURIA that had expired on 30-May-2015 (non serious, outcome: Unknown). Action taken: Discontinued. Event treatment: not provided. Rechallenge/Dechallenge information: not applicable. For relevant test results see appropriate report section. Please add other relevant test results manually as appropriate.
March 25 11 pm started off with chills and  body aches just on legs. March 26 2 am woke up with body aches everywhere and hurting a lot.  8 am woke up with chills, body aches all over, nausea, headache and fever. All of theses symptoms lasted through out the day with the chills and headache going away and coming back. Took Advil, drank water and slept as much as I could to relieve symptoms. Tried to eat but couldn?t eat much due to the nausea. 10/10:30pm went to sleep with all symptoms returning.  March 27 9:30 am woke up drenched in sweat and bed drenched in sweat and symptoms gone as if nothing happened. A little tired and worn out.
No additional AE/PQC; HCP called to inform a patient received MMR II and PROQUAD at the same visit and was not supposed to receive PROQUAD MIR; HCP called to inform a patient received MMR II and PROQUAD at the same visit and was not supposed to receive PROQUAD MIR; This spontaneous report has been received from a medical assistant regarding an 18-year-old patient of unknown gender. The patient's medical history, and concomitant medication were not provided.  On 09-MAY-2023, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), subcutaneous injection, at a dose of 0.5 milliliters, albumin status rHa, administered as prophylaxis, (strength, route of administration and anatomical location were not provided; upon internal review the lot number W007041 was considered as valid and expiration date was established as 29-FEB-2024). On the same date, the patient received a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), subcutaneous injection, at a dose of 0.5 milliliters, albumin status rHa, administered as prophylaxis, (strength, route of administration and anatomical location were not provided; upon internal review the lot number W017570 was considered as valid and expiration date was established as 29-NOV-2023). It was reported that the patient was not supposed to receive the dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (product administered to patient of inappropriate age) (overdose).  No additional adverse event was reported (no adverse event).
Breakthrough case admission after two vaccines Pfizer 06/28/2021 Lot# W0179;  Pfizer 7/26/21 Lot# Ew0179
fever, vomiting onset 36hr p/vax;tx w/APAP;
presented in my garage with stroke symptoms and summoned the paramedics where they performed stroke protocol and took me to local hospital where they did the same and administered tPA.  From onset of symptoms to tPA was approximately 45 minutes.  CT and MRI showed narrowing where embolic debris lodged.
This spontaneous report as received from a field employee via the physician refers to a 15 year old female patient. Concurrent condition, medical history and drug allergies were unspecified. Approximately in 2011, the patient received the first dose of GARDASIL, second dose in 2013 and in April 2015 and with the third dose of GARDASIL. The day after the third dose was given approximately in April 2015, the patient developed tail bone pain. The physician mentioned that the patient's mother was very upset about that and had done extensive research about the dangers of quadrivalent human papilloma (type 6, 11, 16, 18)vaccine online and the mother felt that the patient had aluminum toxicity. It was not confirmed by the physician that whether the patient has aluminum toxicity or not. No lab diagnostics studies were performed. No intervention to prevent serious criteria was reported. No treatment was given. Patient sought medical attention through a phone call. No product quality complaint involved. The outcome of event was reported as not recovered/not resolved. Causality assessment was not provided. Additional information has been requested.
Fatique and myagia 2 hr after injection. Large erythematous local reaction @ injection site. Symptoms intermittent for 6 days. Six days after injection fever 101 -103 for 3 days with increase in myalgia and fatigue. Fever and muscle pain improved with Ibuprofin or Tylenol untilfever returened in 4-5 hrs. Local reaction lasted ten days.